192 related articles for article (PubMed ID: 30030352)
1. Proceedings of the 2017 Viral Clearance Symposium, Session 6: Ensuring Viral Safety in Continuous Processing.
Johnson SA; Roush D
PDA J Pharm Sci Technol; 2018; 72(5):516-524. PubMed ID: 30030352
[TBL] [Abstract][Full Text] [Related]
2. Proceedings of the 2019 Viral Clearance Symposium, Session 3: Continuous Processing.
Lute S; Specht R
PDA J Pharm Sci Technol; 2022; 76(4):315-322. PubMed ID: 34911830
[TBL] [Abstract][Full Text] [Related]
3. Proceedings of the 2017 Viral Clearance Symposium Session 5: Facility Risk Mitigation.
Ma J; Kreil TR
PDA J Pharm Sci Technol; 2018; 72(5):511-515. PubMed ID: 30030359
[TBL] [Abstract][Full Text] [Related]
4. Proceedings of the 2017 Viral Clearance Symposium, Session 2.1: DSP Unit Operations-Virus Filtration/Inactivation.
Kreil TR; Roush D
PDA J Pharm Sci Technol; 2018; 72(5):470-478. PubMed ID: 30030356
[TBL] [Abstract][Full Text] [Related]
5. Proceedings of the 2017 Viral Clearance Symposium, Session 2.2: DSP Unit Operations-Purification Unit Operations.
Roush D; Kreil TR
PDA J Pharm Sci Technol; 2018; 72(5):479-487. PubMed ID: 30030354
[TBL] [Abstract][Full Text] [Related]
6. Proceedings of the 2017 Viral Clearance Symposium.
Hepbildikler S; Nothelfer F
PDA J Pharm Sci Technol; 2018; 72(5):453-454. PubMed ID: 30030350
[TBL] [Abstract][Full Text] [Related]
7. Proceedings of the 2009 Viral Clearance Symposium.
Miesegaes G; Bailey M; Willkommen H; Chen Q; Roush D; Blümel J; Brorson K
Dev Biol (Basel); 2010; 133():3-101. PubMed ID: 21516942
[TBL] [Abstract][Full Text] [Related]
8. Retrospective Evaluation of Cycled Resin in Viral Clearance Studies-A Multiple Company Collaboration.
Mattila J; Curtis S; Webb-Vargas Y; Wilson E; Galperina O; Roush D; Tobler S; Stanley B; Clark M; Weaver J; Pike J; Yu D; Li X; Flicker A; Kindermann J; Schuelke N; Whitcombe R; Bennett L
PDA J Pharm Sci Technol; 2019; 73(5):470-486. PubMed ID: 31101706
[TBL] [Abstract][Full Text] [Related]
9. The Use of Bayesian Hierarchical Logistic Regression in the Development of a Modular Viral Inactivation Claim.
Banton D; Vacante D; Bulthuis B; Goldstein J; Wineburg M; Schreffler J
PDA J Pharm Sci Technol; 2019; 73(6):552-561. PubMed ID: 31101710
[TBL] [Abstract][Full Text] [Related]
10. Virus study for continuous low pH viral inactivation inside a coiled flow inverter.
David L; Maiser B; Lobedann M; Schwan P; Lasse M; Ruppach H; Schembecker G
Biotechnol Bioeng; 2019 Apr; 116(4):857-869. PubMed ID: 30450694
[TBL] [Abstract][Full Text] [Related]
11. Adapting viral safety assurance strategies to continuous processing of biological products.
Johnson SA; Brown MR; Lute SC; Brorson KA
Biotechnol Bioeng; 2017 Jan; 114(1):21-32. PubMed ID: 27474890
[TBL] [Abstract][Full Text] [Related]
12. Proceedings of the 2019 Viral Clearance Symposium, Session 1: Viral Clearance Strategies and Case Studies.
Reitz S; Schwantes A
PDA J Pharm Sci Technol; 2022; 76(4):297-305. PubMed ID: 34911829
[TBL] [Abstract][Full Text] [Related]
13. Proceedings of the 2019 Viral Clearance Symposium, Session 5: Viral Inactivation.
Ma J
PDA J Pharm Sci Technol; 2022; 76(4):339-348. PubMed ID: 34911831
[TBL] [Abstract][Full Text] [Related]
14. Novel spiking methods developed for anion exchange chromatography operating in a continuous process.
Li Y; Chang A; Beattie D; Remington KM
Biotechnol Bioeng; 2020 Nov; 117(11):3379-3389. PubMed ID: 32667685
[TBL] [Abstract][Full Text] [Related]
15. Proceedings of the 2017 Viral Clearance Symposium, Session 4: Submission Strategies.
Schwantes A; Specht R; Chen Q
PDA J Pharm Sci Technol; 2018; 72(5):498-510. PubMed ID: 30030357
[TBL] [Abstract][Full Text] [Related]
16. Biopharmaceutical Industry Approaches to Facility Segregation for Viral Safety: An Effort from the Consortium on Adventitious Agent Contamination in Biomanufacturing.
Barone PW; Avgerinos S; Ballard R; Brussel A; Clark P; Dowd C; Gerentes L; Hart I; Keumurian FJ; Kindermann J; Leung JC; Ly N; Mink S; Minning S; Mullberg J; Murphy M; Nöske K; Parriott S; Shum B; Wiebe ME; Springs SL
PDA J Pharm Sci Technol; 2019; 73(2):191-203. PubMed ID: 30361281
[TBL] [Abstract][Full Text] [Related]
17. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
[TBL] [Abstract][Full Text] [Related]
18. Proceedings of the 2017 Viral Clearance Symposium, Session 3: Resin Lifetime.
Blümel J; Ma J
PDA J Pharm Sci Technol; 2018; 72(5):488-497. PubMed ID: 30030358
[TBL] [Abstract][Full Text] [Related]
19. Process scale considerations in evaluation studies and scale-up.
Walter JK; Werz W; Berthold W
Dev Biol Stand; 1996; 88():99-108. PubMed ID: 9119169
[TBL] [Abstract][Full Text] [Related]
20. Proceedings of the 2017 Viral Clearance Symposium: Conclusion.
Hepbildikler S; Johnson S; Bluemel J
PDA J Pharm Sci Technol; 2018; 72(5):525-530. PubMed ID: 30030353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
